Lacosamide as adjunctive therapy for partial-onset seizures: A randomized controlled trial

Epilepsia

Volumn 51, Issue 6, 2010, Pages 958-967

  Chung, Steve ^a   Sperling, Michael R ^b   Biton, Victor ^c   Krauss, Gregory ^d   Hebert, David ^e   Rudd, G David ^e   Doty, Pamela ^e  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c Arkansas Epilepsy Program   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e Schwarz Biosciences   (United States)

Author keywords

Antiepileptic drugs; Epilepsy; Lacosamide; Partial onset seizures; Randomized controlled trial

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADOLESCENT; ADULT; ARTICLE; BLURRED VISION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COORDINATION DISORDER; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NYSTAGMUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TONIC CLONIC SEIZURE; TREMOR; VOMITING;

ACETAMIDES; ADOLESCENT; ADULT; AGED; DIZZINESS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SEIZURES; YOUNG ADULT;

EID: 77953033494     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02496.x     Document Type: Article

References (21)

1. Andurkar SV, Stables JP, Kohn H. (1999) The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Bioorg Med Chem 7:2381-2389.
2. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:1308-1317. (Pubitemid 47063096)
3. Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stohr T. (2007) Lacosamide: a review of preclinical properties. CNS Drug Rev 13:21-42.
4. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. (2007) Progress report on the new antiepileptic drugs: a summary of the Eighth EILAT Conference (EILAT VIII). Epilepsy Res 73:1-52.
5. Centers for Disease Control and Prevention. (2008) Prevalence of self-reported epilepsy - United States, 1986-1990. JAMA 272:1893.
6. Cramer JA, Ben Menachem E, French J. (2001) Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res 47:17-25.
7. Commission on Classification and Terminology of the International League Against Epilepsy. (1981) Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22:489-501.
8. Errington AC, Stçhr T, Heers C, Lees G. (2008) The investigational anti-convulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol 73:157-169. (Pubitemid 350294207)
9. Forsgren L, Hauser WA, Olafsson E, Sander WAS, Sillanpaä, Tomson T. (2005) Mortality of epilepsy in developed countries: a review. Epilepsia 46(Suppl. 11):18-27.
10. Gazzola DM, Balcer LJ, French JA. (2007) Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs. Epilepsia 48:1303-1307.
11. Halász P, Kälviäinen R, Mazurkiewicz-Beldzińska M, Rosenow F, Doty P, Hebert D. (2009) Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia 50:443-453.
12. Harden CL, Maroof DA, Nikolov B, Fowler K, Sperling M, Liporace J, Pennell P, Labar D, Herzog A. (2007) The effect of seizure severity on quality of life in epilepsy. Epilepsy Behav 11:208-211. (Pubitemid 47279103)
13. Horstmann R, Bonn R, Cawello W, Doty P, Rudd GD (2002) Basic clinical pharmacological investigations of the new antiepileptic drug SPM 927. Epilepsia 43:188. Abstract.
14. Hovinga CA. (2003) SPM-927 (Schwarz Pharma). IDrugs 6:479-485.
15. Kwan P, Brodie MJ. (2007) Emerging drugs for epilepsy. Expert Opin Emerg Drugs 12:407-422.
16. Perucca E. (2007) Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet 6:793-804.
17. Schiller Y, Najjar Y. (2008) Quantifying the response to antiepileptic drugs: Effect of past treatment history. Neurology 70:54-65.
18. Sperling MR. (2004) The consequences of uncontrolled epilepsy. CNS Spectrum 9:98-109.
19. Thomas D, Scharfenecker U, Nickel B, Doty P, Cawello W, Horstmann R. (2006) Low potential for drug-drug interaction of lacosamide. Epilepsia 47:200.
20. Tracy JI, Dechant V, Sperling MR, Cho R, Glosser D. (2007) The association of mood with quality of life ratings in epilepsy. Neurology 68:1101-1107. (Pubitemid 46559843)
21. Wiebe S. (2006) Burden of intractable epilepsy. Adv Neurol 97:1-4.